Literature DB >> 17855072

Pain in oxaliplatin-induced neuropathy--sensitisation in the peripheral and central nociceptive system.

Andreas Binder1, Maike Stengel, Rainer Maag, Gunnar Wasner, Robert Schoch, Frank Moosig, Bernhard Schommer, Ralf Baron.   

Abstract

BACKGROUND: This study aimed to determine the somatosensory characteristics and pain types in patients with acute oxaliplatin-induced neuropathy and to relate this profile to the hereby detected underlying pathophysiological mechanisms. PATIENTS AND METHODS: Sixteen patients treated with oxaliplatin for cancer were characterised with neurological assessment and a standardised and validated set for quantitative sensory testing (QST). Patients were allocated to two groups depending on the presence or absence of pain symptoms of acute neuropathy.
RESULTS: Comparison with normative data revealed in patients with pain symptoms a characteristic somatosensory profile of cold and mechanical hyperalgesia. Group-to-group analysis revealed additional heat hyperalgesia and warm hypoesthesia.
CONCLUSION: Pain symptoms of acute oxaliplatin-induced neuropathy are related to signs of sensitisation within the peripheral (cold and heat hyperalgesia) and central nervous nociceptive system (mechanical hyperalgesia). This strengthens the rationale for treatment with anticonvulsants and antidepressants and fosters research on ion channel and receptor related mechanisms.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17855072     DOI: 10.1016/j.ejca.2007.07.030

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  23 in total

1.  Structure-Based Design of Novel Biphenyl Amide Antagonists of Human Transient Receptor Potential Cation Channel Subfamily M Member 8 Channels with Potential Implications in the Treatment of Sensory Neuropathies.

Authors:  V Blair Journigan; Zhiwei Feng; Saifur Rahman; Yuanqiang Wang; A R M Ruhul Amin; Colleen E Heffner; Nicholas Bachtel; Siyi Wang; Sara Gonzalez-Rodriguez; Asia Fernández-Carvajal; Gregorio Fernández-Ballester; Jacob K Hilton; Wade D Van Horn; Antonio Ferrer-Montiel; Xiang-Qun Xie; Taufiq Rahman
Journal:  ACS Chem Neurosci       Date:  2020-01-09       Impact factor: 4.418

2.  Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel.

Authors:  W H Xiao; H Zheng; G J Bennett
Journal:  Neuroscience       Date:  2011-12-20       Impact factor: 3.590

3.  A quantitative sensory analysis of peripheral neuropathy in colorectal cancer and its exacerbation by oxaliplatin chemotherapy.

Authors:  Mariana de Carvalho Barbosa; Alyssa K Kosturakis; Cathy Eng; Gwen Wendelschafer-Crabb; William R Kennedy; Donald A Simone; Xin S Wang; Charles S Cleeland; Patrick M Dougherty
Journal:  Cancer Res       Date:  2014-09-02       Impact factor: 12.701

4.  Functional deficits in peripheral nerve mitochondria in rats with paclitaxel- and oxaliplatin-evoked painful peripheral neuropathy.

Authors:  Huaien Zheng; Wen Hua Xiao; Gary J Bennett
Journal:  Exp Neurol       Date:  2011-08-30       Impact factor: 5.330

5.  The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA.

Authors:  Sherry L Wolf; Debra L Barton; Rui Qin; Edward J Wos; Jeff A Sloan; Heshan Liu; Neil K Aaronson; Daniel V Satele; Bassam I Mattar; Nathan B Green; Charles L Loprinzi
Journal:  Support Care Cancer       Date:  2011-04-12       Impact factor: 3.603

6.  Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat.

Authors:  Elizabeth K Joseph; Jon D Levine
Journal:  J Pain       Date:  2009-02-23       Impact factor: 5.820

7.  Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivity.

Authors:  Seo-Yeon Yoon; Caleb R Robinson; Haijun Zhang; Patrick M Dougherty
Journal:  J Pain       Date:  2013-02       Impact factor: 5.820

8.  Prechemotherapy Touch Sensation Deficits Predict Oxaliplatin-Induced Neuropathy in Patients with Colorectal Cancer.

Authors:  Xin Shelley Wang; Qiuling Shi; Patrick M Dougherty; Cathy Eng; Tito R Mendoza; Loretta A Williams; David R Fogelman; Charles S Cleeland
Journal:  Oncology       Date:  2016-02-17       Impact factor: 2.935

9.  JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy.

Authors:  Iryna A Khasabova; Xu Yao; Justin Paz; Cutler T Lewandowski; Amy E Lindberg; Lia Coicou; Natasha Burlakova; Don A Simone; Virginia S Seybold
Journal:  Pharmacol Res       Date:  2014-10-07       Impact factor: 7.658

Review 10.  Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancer.

Authors:  Cathy Eng
Journal:  Nat Rev Clin Oncol       Date:  2009-04       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.